Dawn Baker
Impact in
-
- Cancer, Hypoxia, and Metabolism
-
- Fibroblast Growth Factor Research
- Kruppel-like factors research
- Epigenetics and DNA Methylation
- Angiogenesis and VEGF in Cancer
Papers in
-
- Fibroblast Growth Factor Research 5
- Angiogenesis and VEGF in Cancer 3
- Epigenetics and DNA Methylation 2
- Kruppel-like factors research 2
-
- Cancer, Hypoxia, and Metabolism 4
- Breast Cancer Treatment Studies 1
- Co-authors
- Elaine Kilgour (5 shared papers)Claire Rooney (4 shared papers)Katherine Al-Kadhimi (3 shared papers)Lorraine Mooney (3 shared papers)Tanya Coleman (2 shared papers)Paul R. Gavine (2 shared papers)Martine J. Mellor (2 shared papers)Andrew P. Thomas (2 shared papers)
- Journals
- Molecular Cancer Therapeutics (2 papers)Clinical Cancer Research (2 papers)Cancer Research (2 papers)Journal of Clinical Oncology (1 paper)PLoS ONE (1 paper)
- Partner nations
- United KingdomUnited StatesCzechia
In The Last Decade
Dawn Baker
8 papers receiving 821 citations
Hit Papers
Peers
Comparison fields: 5 of 74
- Cancer Research 157
- Molecular Biology 623
- Oncology 233
- Pulmonary and Respiratory Medicine 157
- Immunology and Allergy 24
Countries citing papers authored by Dawn Baker
This map shows the geographic impact of Dawn Baker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dawn Baker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dawn Baker more than expected).
Fields of papers citing papers by Dawn Baker
This network shows the impact of papers produced by Dawn Baker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dawn Baker. The network helps show where Dawn Baker may publish in the future.
Co-authors
The 25 scholars most cited alongside Dawn Baker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | AZD4547: An Orally Bioavailable, Potent, and Selective Inhibitor of the Fibroblast Growth Factor Receptor Tyrosine Kinase Family Hit paper breakdown → | 2012 | 415 |
| 2 | 2010 | 197 | |
| 3 | 2013 | 111 | |
| 4 | 2012 | 47 | |
| 5 | 2016 | 21 | |
| 6 | 2016 | 18 | |
| 7 | 2014 | 15 | |
| 8 | 2011 | 11 |
About Dawn Baker
Dawn Baker is a scholar working on Molecular Biology, Cancer Research, Oncology, Pulmonary and Respiratory Medicine and Rheumatology, having authored 8 papers that have together received 835 indexed citations. Recurring topics across this work include Fibroblast Growth Factor Research (5 papers), Cancer, Hypoxia, and Metabolism (4 papers), Angiogenesis and VEGF in Cancer (3 papers), Epigenetics and DNA Methylation (2 papers), Kruppel-like factors research (2 papers), Lymphatic System and Diseases (1 paper), Breast Cancer Treatment Studies (1 paper) and Metastasis and carcinoma case studies (1 paper). The work is most often cited by research in Cancer Research (157 citations), Molecular Biology (623 citations), Oncology (233 citations), Pulmonary and Respiratory Medicine (157 citations) and Immunology and Allergy (24 citations). Dawn Baker has collaborated with scholars based in United Kingdom, United States and Czechia. Frequent co-authors include Elaine Kilgour, Claire Rooney, Katherine Al-Kadhimi, Lorraine Mooney, Tanya Coleman, Paul R. Gavine, Martine J. Mellor, Andrew P. Thomas, Teresa Klinowska and Sarah Beck. Their work appears in journals such as Molecular Cancer Therapeutics, Clinical Cancer Research, Cancer Research, Journal of Clinical Oncology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.